News

News Archive

Continuous blood glucose monitoring: the Menarini Diagnostics digital “patch” now available!

Continuous blood glucose monitoring: the Menarini Diagnostics digital “patch” now available!

Measuring blood sugar several times a day for people with diabetes, will no longer be necessary. Menarini Diagnostics has launched GlucoMen® Day CGM, an innovative digital patch,...
Menarini Group Completes a Solid Year of Operating Performance

Menarini Group Completes a Solid Year of Operating Performance

Menarini Group Completes a Solid Year of Operating Performance

Turnover reaches nearly € 3.8 billion (€3,793 million), with an increase of 3.2% compared to2018, and EBITDA of €492 million. Growth was mainly driven by international...
Menarini Group Completes Acquisition of Stemline Therapeutics

Menarini Group Completes Acquisition of Stemline Therapeutics

Menarini Group Completes Acquisition of Stemline Therapeutics

Menarini Group today announced that is has successfully completed the acquisition of Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development...
Menarini invests 150 million euros in a new pharmaceutical plant in Italy

Menarini invests 150 million euros in a new pharmaceutical plant in Italy

Menarini invests 150 million euros in a new pharmaceutical plant in Italy

Menarini chooses Italy for its new €150 million manufacturing site.

Select a Year from the Archive

Our values

Our values

Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history.

Read More

Our values

Go to Follow our blog

Follow our blog

Discover our stories from all over the world

Read More